ECSP961826A - NEW FORMULATION - Google Patents

NEW FORMULATION

Info

Publication number
ECSP961826A
ECSP961826A ECSP961826A ECSP961826A EC SP961826 A ECSP961826 A EC SP961826A EC SP961826 A ECSP961826 A EC SP961826A EC SP961826 A ECSP961826 A EC SP961826A
Authority
EC
Ecuador
Prior art keywords
new formulation
ssri
paroxetine
formulation containing
serotonin reuptake
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Stanley Leonard Graham
David Philip Elder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961826 priority Critical patent/ECSP961826A/en
Publication of ECSP961826A publication Critical patent/ECSP961826A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una formulación de liberación controlada o de liberación retardada que contiene un inhibidor selectivo de la reabsorción de serotonina (ISRS) tal como para paroxetina.A controlled release or delayed release formulation containing a selective serotonin reuptake inhibitor (SSRI) such as for paroxetine.

ECSP961826 1996-07-18 1996-07-18 NEW FORMULATION ECSP961826A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961826 ECSP961826A (en) 1996-07-18 1996-07-18 NEW FORMULATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961826 ECSP961826A (en) 1996-07-18 1996-07-18 NEW FORMULATION

Publications (1)

Publication Number Publication Date
ECSP961826A true ECSP961826A (en) 1997-11-20

Family

ID=42042556

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961826 ECSP961826A (en) 1996-07-18 1996-07-18 NEW FORMULATION

Country Status (1)

Country Link
EC (1) ECSP961826A (en)

Similar Documents

Publication Publication Date Title
UY26242A1 (en) NEW FORMULATION LAW 17164
AR007609A1 (en) A PHARMACEUTICAL COMPOSITION
DK2253620T3 (en) SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN-TYROSINKINASE INHIBITORS
DK0946512T3 (en) 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors
NO20005454D0 (en) Novel hydroxy indoles, their use as phosphodiesterase 4 inhibitors and process for their preparation
NO20016406L (en) High selective reuptake inhibitors for norepinephrine
MXPA02001919A (en) Phenylpiperazines as serotonin reuptake inhibitors.
DK0840606T3 (en) Small di- and trivalent molecules as selectin inhibitors
ES2190205T3 (en) COMBINATION FOR THE TREATMENT OF THE ALCOHOL DEPENDENCE CONTAINING AN OPIOID ANTAGONIST AND A NMDA RECEPTOR COMPLEX MODULATOR.
MX9200762A (en) DERIVED FROM INDOL, PROCEDURE FOR ITS REPAIR AND COMPOSITION THAT CONTAINS THEM.
AR015837A1 (en) METHOD OF TRANSFORMATION OF PLANTS.
NO20030842D0 (en) Phenoxybenzylamine derivatives as selective serotonin reuptake inhibitors
NO980178L (en) Cyclooxygenase inhibitor and amidine derivative salts, process for their preparation, use thereof as drugs, and pharmaceutical compositions containing such derivatives
FI965074A7 (en) Tropane-2-aldoxin derivatives as neurotransmitter reuptake inhibitors
ES2104358T3 (en) SILILED ACETYLCHOLINESTERASE INHIBITORS.
ES2187738T3 (en) DERIVATIVES OF FLAVONAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOUNDS THAT CONTAIN THEM.
NO991994L (en) Substituted 4-biphenyl-4-hydroxy acid derivatives as matrix metalloprotease inhibitors
MX9200731A (en) HYDRAZONE COMPOUNDS, PROCEDURES FOR ITS HYDRAZONE COMPOUNDS, PROCEDURES FOR ITS PREPARATION, INTERMEDIATE COMPOUNDS USEFUL FOR ITS OPERATION, INTERMEDIATE COMPOUNDS USEFUL FOR ITS OBTAINMENT AND PESTICIDED COMPOSITIONS THAT CONTAIN MESSAGE AND MISCELLANEOUS COMPOSITIONS CONTAINING BTENTIONAL COMPOSITIONS. THE SAME.
UY28148A1 (en) SCITALOPRAM BROMHYDRATE AND A METHOD FOR PREPARATION
AU2002224938A1 (en) Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
AR025351A1 (en) PAR SELECTIVE RETINOID AGONISTS
NO981019D0 (en) Deodorizing preparations containing cationic biopolymers, aluminum chlorohydrate and esterase inhibitors
ECSP961826A (en) NEW FORMULATION
ZA974033B (en) Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors.
ES2175661T3 (en) DERIVATIVES OF ISOFLAVONA, PROCEDURES FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.